Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Onkologie is Scopus-indexed (Q4, CiteScore 0.3), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer Medizin.
Checked against the index lists dated .
ISSN 2731-7226Verify ISSN ↗2731-7234Verify ISSN ↗
Publisher: Springer Medizin
Cost to publish: About US$3,390 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 140 / 151 | 7th | Q4 |
| Oncology | 396 / 428 | 7th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present, best quartile Q4, CiteScore 0.3.
Onkologie is Q4 in Hematology (rank 140 of 151) and Q4 in Oncology (rank 396 of 428), by CiteScore 2025.
Onkologie is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.3, which places it in quartile Q4 at the 7th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.128, quartile Q4, with an H-index of 16.
The publisher lists an article processing charge of about US$3,390 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Onkologie is published by Springer Medizin. Its print ISSN is 2731-7226 and its online ISSN is 2731-7234.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Onkologie has an h-index of 6 and a 2-year mean of 0.26 citations per paper (OpenAlex). Its Scopus CiteScore is 0.3, quartile Q4. On 2-year citations it ranks #126 of 148 Scopus journals in Hematology.
Onkologie published 230 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 80 research articles (2026), authors are most often from Germany (90.6%), Austria (5%) and Switzerland (3.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (1.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.